Response to letter regarding ‘Anterior quadratus lumborum block at the lateral supra-arcuate ligament versus thoracic paravertebral block for postoperative analgesia after laparoscopic nephrectomy: a randomized non-inferiority trial’ Authors: Shu-Qin He, Peng Ye, Ting Zheng Published: 2026 Dear Editor We appreciate the constructive feedback and thoughtful suggestions from readers on our recently published paper, ‘Anterior quadratus lumborum block at the lateral supra-arcuate ligament versus thoracic paravertebral block for postoperative analgesia after laparoscopic nephrectomy: a randomized non-inferiority trial’ [1]. We sincerely appreciate their engagement with our research and have carefully considered every piece of feedback. Firstly, this study selects CSBA as the observation indicator for the following key reasons:The spinal and sympathetic nerves within the paravertebral space are located deep within the tissue, making it impossible to monitor their electrophysiological activity in real-time at the bedside. Cutaneous sensory testing, as a non-invasive, immediate, and repeatable ‘functional assessment,’ can translate the abstract effects of nerve blockade into a clear, well-defined map of sensory block distribution on the body surface. This provides an intuitive and practical basis for clinical evaluation.The surgical incision and corresponding manoeuvres map to specific dermatomes. Therefore, the preoperatively assessed cutaneous block area can serve as a direct predictor of whether somatic analgesia will adequately cover the surgical site.Abnormal or unexpectedly extensive loss of skin sensation may indicate unintended spread of local anaesthetic (e.g. into the epidural space). This can serve as an important early clinical clue for identifying potential complications. The spinal and sympathetic nerves within the paravertebral space are located deep within the tissue, making it impossible to monitor their electrophysiological activity in real-time at the bedside. Cutaneous sensory testing, as a non-invasive, immediate, and repeatable ‘functional assessment,’ can translate the abstract effects of nerve blockade into a clear, well-defined map of sensory block distribution on the body surface. This provides an intuitive and practical basis for clinical evaluation. The spinal and sympathetic nerves within the paravertebral space are located deep within the tissue, making it impossible to monitor their electrophysiological activity in real-time at the bedside. Cutaneous sensory testing, as a non-invasive, immediate, and repeatable ‘functional assessment,’ can translate the abstract effects of nerve blockade into a clear, well-defined map of sensory block distribution on the body surface. This provides an intuitive and practical basis for clinical evaluation. The surgical incision and corresponding manoeuvres map to specific dermatomes. Therefore, the preoperatively assessed cutaneous block area can serve as a direct predictor of whether somatic analgesia will adequately cover the surgical site. The surgical incision and corresponding manoeuvres map to specific dermatomes. Therefore, the preoperatively assessed cutaneous block area can serve as a direct predictor of whether somatic analgesia will adequately cover the surgical site. Abnormal or unexpectedly extensive loss of skin sensation may indicate unintended spread of local anaesthetic (e.g. into the epidural space). This can serve as an important early clinical clue for identifying potential complications. Abnormal or unexpectedly extensive loss of skin sensation may indicate unintended spread of local anaesthetic (e.g. into the epidural space). This can serve as an important early clinical clue for identifying potential complications. Regarding whether the CSBA can reflect visceral analgesic efficacy: The sensation of skin in the chest wall and abdomen is dominated by the lateral and anterior branches of the intercostal nerves, which originate from the thoracolumbar spinal nerves, whereas the visceral pain of the renal area is dominated by the small branches of the visceral nerve that originate from the preganglionic fibres of the sympathetic ganglia from T9 to T11 [2]. Although they are innervated by different nerves, spinal nerves are connected to the corresponding sympathetic trunk ganglia near the intervertebral foramina via gray and white rami communicantes, creating a functional integration mechanism between somatic dermatomal block and visceral nerve block [3]. Therefore, the cutaneous sensory block area can indirectly reflect, to some extent, the status of visceral nerve blockade. This is precisely why this indicator is widely used to assess the efficacy of nerve blocks [4–6]. We also recognize that the CSBA cannot be equated entirely with the degree of visceral nerve blockade. Future studies could further correlate CSBA with dynamic intraoperative biomarkers (e.g. autonomic nervous system responses during renal pedicle traction), thereby enabling a more systematic exploration of the intrinsic relationship between somatic blockade and visceral analgesia. Secondly, this study adopted the VAS score as the primary tool for assessing postoperative pain intensity. The VAS score enables objective quantification of patients’ subjective pain experience and directly reflects the severity of postoperative pain, serving as key evidence for directly evaluating the effectiveness of multimodal analgesia. Therefore, it was designated as the primary outcome in this study. Although postoperative recovery-related indicators (such as time to first ambulation and length of hospital stay) are also associated with analgesic efficacy, they are simultaneously influenced by multiple confounding factors, including patients’ baseline conditions, the extent of surgical trauma, and postoperative complications (e.g. infection). To more precisely focus on the effect of the analgesic intervention per se, this study designated the aforementioned recovery indicators as secondary outcome measures. Together with the primary indicators, they are used to systematically evaluate the analgesic efficacy and clinical benefits of different nerve block techniques. Finally, the authors note that this study lacks a health economic analysis, thereby limiting its clinical translational value—a perspective with which we fully concur. Future research should incorporate more real-world evaluation metrics (e.g. time required per block procedure, incidence of block‑related adverse events, and total duration of analgesia) to further assess whether QLB‑LSAL has the potential and value to serve as an alternative to TPVB. Thank you again for your feedback.